Recent News
The Pink Sheet - CBO Says Senate User Fee Package Will Decrease Direct Spending
By DERRICK GINGERY
The Congressional Budget Office’s score of the Senate FDA user fee package should please the legislators because while new FDA mandates are expected to increase costs, the net effect of the package is expected to decrease the price of drugs
Reuters - U.S. may speed approval of 'breakthrough' drugs
By ANNA YUKHANANOV
U.S. drug regulators would be able to label such treatments "breakthrough" therapies, and work with companies to speed up clinical trials, for example by testing the drugs for a shorter time or enrolling fewer patients.
NIH launches collaborative program with industry and researchers to spur therapeutic development
The National Institutes of Health today unveiled a collaborative program that will match researchers with a selection of pharmaceutical industry compounds to help scientists explore new treatments for patients.
Upcoming Events
-
September 14, 2012 - September 14, 2012
Forum on Co-development of Targeted Therapies and Companion Diagnostics
On September 14, 2012, Friends of Cancer Research will hold a half-day forum to bring together researchers, sponsors, advocates and regulators to discuss the opportunities and challenges associated with co-development of drugs and the diagnostic tests used to determine which patients should receive the treatment. An...









